Drugs / Optive Advanced
last change Sep 2017 re-read 2 minutes ago

Optive Advanced

Developed for
dry eye syndrome

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02871440 Comparator Sep 2016 → Sep 2017 dry eye syndrome The University of New South Wales Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Optive Advanced ClinicalTrials.gov intervention name — accepted as the source's own label NCT02871440
Route Other “Eye drop 2” NCT02871440